Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ProQR Therapeutics N.V (PRQR) Non-Current Deferred Tax Liability: 2022-2024

Historic Non-Current Deferred Tax Liability for ProQR Therapeutics N.V (PRQR) over the last 3 years, with Dec 2024 value amounting to $3.2 million.

  • ProQR Therapeutics N.V's Non-Current Deferred Tax Liability fell 21.81% to $3.2 million in Q4 2024 from the same period last year, while for Dec 2024 it was $3.2 million, marking a year-over-year decrease of 21.81%. This contributed to the annual value of $3.2 million for FY2024, which is 22.23% down from last year.
  • Per ProQR Therapeutics N.V's latest filing, its Non-Current Deferred Tax Liability stood at $3.2 million for FY2024, which was down 22.23% from $4.1 million recorded in FY2023.
  • Over the past 5 years, ProQR Therapeutics N.V's Non-Current Deferred Tax Liability peaked at $4.1 million during FY2023, and registered a low of $3.2 million during FY2024.
  • Over the past 3 years, ProQR Therapeutics N.V's median Non-Current Deferred Tax Liability value was $3.8 million (recorded in 2022), while the average stood at $3.7 million.
  • As far as peak fluctuations go, ProQR Therapeutics N.V's Non-Current Deferred Tax Liability grew by 6.31% in 2023, and later decreased by 22.23% in 2024.
  • Yearly analysis of 3 years shows ProQR Therapeutics N.V's Non-Current Deferred Tax Liability stood at $3.8 million in 2022, then rose by 6.31% to $4.1 million in 2023, then declined by 22.23% to $3.2 million in 2024.